Cargando…

Curability of Multiple Myeloma

Among 792 patients with multiple myeloma treated from 1987 to 2010 and assessed after 18 months, there were 167 patients with complete remission. For those 60 patients treated between 1987–1998 and with long followup, the latest relapse occurred after 11.8 years, so that 13 patients have remained in...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexanian, Raymond, Delasalle, Kay, Wang, Michael, Thomas, Sheeba, Weber, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366198/
https://www.ncbi.nlm.nih.gov/pubmed/22675638
http://dx.doi.org/10.1155/2012/916479
_version_ 1782234716277047296
author Alexanian, Raymond
Delasalle, Kay
Wang, Michael
Thomas, Sheeba
Weber, Donna
author_facet Alexanian, Raymond
Delasalle, Kay
Wang, Michael
Thomas, Sheeba
Weber, Donna
author_sort Alexanian, Raymond
collection PubMed
description Among 792 patients with multiple myeloma treated from 1987 to 2010 and assessed after 18 months, there were 167 patients with complete remission. For those 60 patients treated between 1987–1998 and with long followup, the latest relapse occurred after 11.8 years, so that 13 patients have remained in sustained complete remission for longer than 12 years (range 12–22 years). These results suggest that 3% of all patients treated during that period may be cured of multiple myeloma. In addition to immunofixation, more sensitive techniques for the detection of residual disease should be applied more consistently in patients with apparent complete remission in order to identify those with potential cure.
format Online
Article
Text
id pubmed-3366198
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33661982012-06-06 Curability of Multiple Myeloma Alexanian, Raymond Delasalle, Kay Wang, Michael Thomas, Sheeba Weber, Donna Bone Marrow Res Review Article Among 792 patients with multiple myeloma treated from 1987 to 2010 and assessed after 18 months, there were 167 patients with complete remission. For those 60 patients treated between 1987–1998 and with long followup, the latest relapse occurred after 11.8 years, so that 13 patients have remained in sustained complete remission for longer than 12 years (range 12–22 years). These results suggest that 3% of all patients treated during that period may be cured of multiple myeloma. In addition to immunofixation, more sensitive techniques for the detection of residual disease should be applied more consistently in patients with apparent complete remission in order to identify those with potential cure. Hindawi Publishing Corporation 2012 2012-05-23 /pmc/articles/PMC3366198/ /pubmed/22675638 http://dx.doi.org/10.1155/2012/916479 Text en Copyright © 2012 Raymond Alexanian et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Alexanian, Raymond
Delasalle, Kay
Wang, Michael
Thomas, Sheeba
Weber, Donna
Curability of Multiple Myeloma
title Curability of Multiple Myeloma
title_full Curability of Multiple Myeloma
title_fullStr Curability of Multiple Myeloma
title_full_unstemmed Curability of Multiple Myeloma
title_short Curability of Multiple Myeloma
title_sort curability of multiple myeloma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366198/
https://www.ncbi.nlm.nih.gov/pubmed/22675638
http://dx.doi.org/10.1155/2012/916479
work_keys_str_mv AT alexanianraymond curabilityofmultiplemyeloma
AT delasallekay curabilityofmultiplemyeloma
AT wangmichael curabilityofmultiplemyeloma
AT thomassheeba curabilityofmultiplemyeloma
AT weberdonna curabilityofmultiplemyeloma